Phase
Condition
Prostate Cancer
Urologic Cancer
Prostate Cancer, Early, Recurrent
Treatment
Multi-port transperitoneal robotic-assisted radical prostatectomy with bilateral intrafascial nerve-sparing techniques
Single-port extraperitoneal robotic-assisted radical prostatectomy with Vattikuti Institute Prostatectomy(VIP) techniques
Clinical Study ID
Ages 18-75 Male
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Men aged 18 years ≤ age ≤ 75 years;
Prostate biopsy within 6 months with diagnosis of organ-localized prostate cancerwith preoperative staging of T1c to T2b,N0M0;.
Gleason Score<8.
PSA<20ng/ml.
Pathologic diagnosis of prostate follicular adenocarcinoma or prostate ductaladenocarcinoma;
The patient has healthy sexual function before surgery and intention for sexualactivities after surgery;
Physiological condition acceptable for laparoscopic surgery;
Willing to cooperate and complete the study follow-up and related examinations;
The subject or his agent voluntarily participates in this trial and signs thewritten informed consent;
The questionnaire can be completed in Chinese.
The patient has been informed of the trial;
Exclusion
Exclusion Criteria:
High-risk and non-organ localized prostate cancer (clinical stage ≥ T2c, GS ≥ 8, PSA > 20ng/ml);
Special type of prostate cancer, such as neuroendocrine etc.;
History of previous abdominal surgery and radiotherapy which may affect abdominalincision and Port placement;
Recent surgery of rectum, perianal abscess or around fistula and perineal area;
Patients who have undergone previous electro-prostatectomy/enucleation of theprostate;
Non-recurrent patients with less than 12 months of follow-up;
ECOG>1.
Combination of other systemic tumors;
had received any type of preoperative antitumor therapy;
Suffering from poor general condition with the presence of one of the followingconditions: including severe mental disorders, cardiovascular disease, activeinfections, bone marrow transplantation within 3 months, or significantabnormalities in organ function;
Participation in other clinical studies or previous treatment with any gene therapyproduct within the last 3 months;
Other conditions that the researchers believe may affect the experimental results orare unethical;
Study Design
Study Description
Connect with a study center
Changzheng hospital
Shanghai, Shanghai 201109
ChinaActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.